Aldurazyme for Mucopolysaccharidosis I (Hurler/Scheie syndrome)
Quick answer: Aldurazyme is used for Mucopolysaccharidosis I (Hurler/Scheie syndrome) as part of a enzyme replacement therapy treatment regimen. Laronidase, recombinant human ฮฑ-L-iduronidase that degrades accumulated glycosaminoglycans The specific dosing for Mucopolysaccharidosis I (Hurler/Scheie syndrome) is determined by your prescriber based on individual factors.
Why is Aldurazyme used for Mucopolysaccharidosis I (Hurler/Scheie syndrome)?
Aldurazyme belongs to the Enzyme replacement therapy class. Laronidase, recombinant human ฮฑ-L-iduronidase that degrades accumulated glycosaminoglycans This action makes it useful for treating or managing Mucopolysaccharidosis I (Hurler/Scheie syndrome) in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Aldurazyme is the right choice for a specific patient depends on the type and severity of Mucopolysaccharidosis I (Hurler/Scheie syndrome), response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Mucopolysaccharidosis I (Hurler/Scheie syndrome)
Common adult dosing range: 0.58 mg/kg IV infusion once weekly. The actual dose for Mucopolysaccharidosis I (Hurler/Scheie syndrome) depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Aldurazyme medicine page.
What to expect
Aldurazyme treatment for Mucopolysaccharidosis I (Hurler/Scheie syndrome) typically involves:
- Onset of effect: varies by indication and dose โ some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Mucopolysaccharidosis I (Hurler/Scheie syndrome)
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Aldurazyme is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Enzyme replacement therapy for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Aldurazyme
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Aldurazyme full prescribing information ยท All Enzyme replacement therapy alternatives
Frequently asked questions
How effective is Aldurazyme for Mucopolysaccharidosis I (Hurler/Scheie syndrome)?
Effectiveness varies by individual response, dose, and severity. Aldurazyme is one of several treatment options for Mucopolysaccharidosis I (Hurler/Scheie syndrome), supported by clinical evidence within the enzyme replacement therapy class. Discuss expected response with your prescriber.
How long do I need to take Aldurazyme for Mucopolysaccharidosis I (Hurler/Scheie syndrome)?
Treatment duration depends on the nature of Mucopolysaccharidosis I (Hurler/Scheie syndrome) โ some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Aldurazyme when used for Mucopolysaccharidosis I (Hurler/Scheie syndrome)?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Aldurazyme for Mucopolysaccharidosis I (Hurler/Scheie syndrome)?
Yes. Multiple medicines and non-drug options exist for Mucopolysaccharidosis I (Hurler/Scheie syndrome). Alternatives within the enzyme replacement therapy class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.